Skip to content

High sexually transmitted infection rates among men on PrEP supports more frequent monitoring

Sarit Golub at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Transgender people are at high risk for HIV, but too little is known about prevention and treatment for this population

Tonia Poteat at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Rapid rise in PrEP awareness in US gay men, but only 5% have used PrEP

Indiana HIV epidemic among people who inject drugs is controlled, but ongoing vigilance is needed

John Brooks and Sumanthi Ramachandran at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Maraviroc may work as PrEP in combination with another drug – but probably not by itself

Roy Gulick presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Expanding treatment and PrEP could prevent 185,000 new HIV infections, US CDC says

Expanding treatment and PrEP could prevent 185,000 new HIV infections, US CDC says

Modest kidney function decline in people taking Truvada for PrEP supports need for monitoring

Albert Liu presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

‘On-demand’ rectal microbicide gel has reasonable tolerability and acceptability – daily less so

Ross Cranston presenting at CROI 2016. Photo by Liz Highleyman, hivandhepatitis.com

Condom use in French PrEP trial: half only used PrEP, a quarter used condoms and PrEP, one in six used neither